Abstract
Background: Data mining publications and patent data can provide decision support for scientists, inventors and industry in the field of cancer research.
Objective: The main objective of this article it to identify trends of research and patent generation productivity originating from Latin American countries in the field of cancer. Method: Publications were collected from the Scopus, Web of Science, PubMed database; and patents were collected from Latipat Espacenet databases. Data from January 1, 2000 until December 31, 2014 were searched for documents with specific words in cancer as a ‘‘topic’’ and a list of 20 Latin American countries as affiliation country. Results: A total of 12,989 items published and 244 patent applications including “cancer” were retrieved. Brazil, Mexico, Argentina, Chile and Peru were highest contributors in cancer research, while Brazil, Mexico, Cuba and Argentina were highest contributors in cancer patent applications. Conclusion: The analysis of the data from this study provides an overview of research and patent activity in Latin America in the cancer field, which can be useful to help health policy makers and people in academia to shape up cancer research in the future.Keywords: Bibliometric, cancer, landscape, Latin America, patent, translational.
Recent Patents on Anti-Cancer Drug Discovery
Title:Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents
Volume: 12 Issue: 1
Author(s): Martin Perez-Santos, Maricruz Anaya-Ruiz and Cindy Bandala
Affiliation:
Keywords: Bibliometric, cancer, landscape, Latin America, patent, translational.
Abstract: Background: Data mining publications and patent data can provide decision support for scientists, inventors and industry in the field of cancer research.
Objective: The main objective of this article it to identify trends of research and patent generation productivity originating from Latin American countries in the field of cancer. Method: Publications were collected from the Scopus, Web of Science, PubMed database; and patents were collected from Latipat Espacenet databases. Data from January 1, 2000 until December 31, 2014 were searched for documents with specific words in cancer as a ‘‘topic’’ and a list of 20 Latin American countries as affiliation country. Results: A total of 12,989 items published and 244 patent applications including “cancer” were retrieved. Brazil, Mexico, Argentina, Chile and Peru were highest contributors in cancer research, while Brazil, Mexico, Cuba and Argentina were highest contributors in cancer patent applications. Conclusion: The analysis of the data from this study provides an overview of research and patent activity in Latin America in the cancer field, which can be useful to help health policy makers and people in academia to shape up cancer research in the future.Export Options
About this article
Cite this article as:
Perez-Santos Martin, Anaya-Ruiz Maricruz and Bandala Cindy, Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents, Recent Patents on Anti-Cancer Drug Discovery 2017; 12 (1) . https://dx.doi.org/10.2174/1574892811666161013114413
DOI https://dx.doi.org/10.2174/1574892811666161013114413 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3
(Tim-3) in Designing Novel Immunotherapy for Bladder Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Testing and Personalized Treatment of Lung Cancer
Current Molecular Pharmacology Targeting Protein Degradation in the Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Tirapazamine: From Bench to Clinical Trials
Current Clinical Pharmacology Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
Current Genomics Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Current Cancer Drug Targets Bothrops pauloensis Snake Venom Toxins: The Search for New Therapeutic Models
Current Topics in Medicinal Chemistry Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis
Current Pharmaceutical Design Anti-cancer Potential of Phyto-alkaloids: A Prospective Review
Current Cancer Therapy Reviews Therapeutic Applications of Crocus sativus L. (Saffron): A Review
The Natural Products Journal HPV mRNA Testing in Triage of Women with ASC-US Cytology May Reduce the Time for CIN2+ Diagnosis Compared with Repeat Cytology
Current Pharmaceutical Design Fibroblast Growth Factor Receptor Signaling in Cancer Biology and Treatment
Current Signal Transduction Therapy Venous Collateral Circulation of the Extracranial Cerebrospinal Outflow Routes
Current Neurovascular Research Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers
Current Drug Metabolism Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Armed Oncolytic Adenoviruses and Polymer-shielded Nanocomplex for Systemic Delivery
Current Cancer Therapy Reviews Multifunctional Lipoic Acid Conjugates
Current Medicinal Chemistry The Problem of False-Positive Human Papillomavirus DNA Tests in Cervical Screening
Current Pharmaceutical Design Application of Proteome Analysis to the Assessment of Prognosis and Response Prediction in Clinical Oncology
Current Cancer Drug Targets